Histotype | Species | Cell Line or Tumor Fragment | Cancer | Growth Curve | Spotlight |
Adrenal | Human | NCI-H295R | Adrenocortical Carcinoma | ||
Bladder | Human | 5637 | Transitional Cell Carcinoma | ||
HT-1376 | Transitional Cell Carcinoma | ||||
J82 | Transitional Cell Carcinoma | ||||
RT112 | Transitional Cell Carcinoma | ||||
SW 780 | Transitional Cell Carcinoma | View Growth Curve | |||
SW 780-Luc-mCh-Puro | Transitional Cell Carcinoma | View Growth Curve | |||
T24 | Transitional Cell Carcinoma | ||||
T24-Luc-Neo | Transitional Cell Carcinoma | ||||
UM-UC-3 | Urothelial Bladder Carcinoma | ||||
Mouse | MB49 | Bladder Carcinoma | |||
MB49-Luc-mCh-Puro | Bladder Carcinoma | ||||
MBT-2 | Bladder Carcinoma | ||||
Bone | Human | MG-63 | Osteosarcoma | ||
Saos-2 | Osteosarcoma | ||||
Saos-2-Luc-mCh-Puro | Osteosarcoma | ||||
SJSA-1 | Osteosarcoma |
| |||
SJSA-1-Luc-mCh-Puro | Osteosarcoma | ||||
SW 1353 | Chondrosarcoma | ||||
Mouse | K7M2 wt | Osteosarcoma | |||
K7M2 wt-Luc-mCh-Puro | Osteosarcoma | ||||
Bone Marrow | Human | A3 | T-Cell Acute Lymphoblastic Leukemia | ||
AML-193 | Acute Myeloid Leukemia | ||||
ARH-77 | Multiple Myeloma | ||||
CCRF-CEM | T-Cell Acute Lymphoblastic Leukemia | ||||
DND-41-Luc-mCh-Puro | T-Cell Acute Lymphoblastic Leukemia | ||||
EOL-1 | Acute Myeloid Leukemia (eosinophilic) | ||||
HEL 92.1.7 | Acute Myeloid Leukemia (erythroblastic) | ||||
HEL 92.1.7-Luc-Neo | Acute Myeloid Leukemia (erythroblastic) | ||||
HEL | Acute Myeloid Leukemia (erythroblastic) | ||||
HEL-Luc-Neo | Acute Myeloid Leukemia (erythroblastic) |
| |||
HL-60 | Acute Promyelocytic Leukemia | ||||
HL-60-Luc-mCh-Puro | Acute Promyelocytic Leukemia | View Growth Curve | |||
JJN3 | Multiple Myeloma (plasma cell) | ||||
JJN-3-Luc-G418R | Multiple Myeloma |
| |||
| Jurkat-Clone E6-1 | T-Cell Acute Lymphoblastic Leukemia | ||||
K-562 | Chronic Myeloid Leukemia | ||||
K-562-Luc2 | Chronic Myeloid Leukemia | ||||
Kasumi-1 | Acute Myeloid Leukemia |
| |||
Kasumi-3 | Acute Myeloid Leukemia | ||||
Kasumi-3-Luc-mCh-Puro | Acute Myeloid Leukemia | ||||
KG-1 | Acute Myeloid Leukemia | ||||
KG-1-Luc-mCh-Puro | Acute Myeloid Leukemia | ||||
KMS-11 | Multiple Myeloma | ||||
KMS-26 | Multiple Myeloma | ||||
KMS-34 | Multiple Myeloma | ||||
KU812 | Chronic Myeloid Leukemia (basophilic) | ||||
L363 | Multiple Myeloma (plasma cell) | ||||
MM.1S-Luc-Neo | Multiple Myeloma | ||||
MOLM-13 | Acute Myeloid Leukemia | ||||
MOLM-13-Luc-mCh-Puro | Acute Myeloid Leukemia | View Growth Curve | |||
MOLM-16 | Acute Myeloid Leukemia (megakaryoblastic) | ||||
MOLT-4 | T-Cell Acute Lymphoblastic Leukemia | ||||
MOLT-4-Luc-mCh-Puro | T-Cell Acute Lymphoblastic Leukemia | ||||
MV-4-11 | Acute Myeloid Leukemia | ||||
MV-4-11-Luc-mCh-Puro | Acute Myeloid Leukemia | ||||
NALM6 | B-cell Acute Lymphoblastic Leukemia | ||||
NALM6-Luc-mCh-Puro | B-cell Acute Lymphoblastic Leukemia | ||||
NCI-H929 | Multiple Myeloma | ||||
NCI-H929-Luc-mCh-Puro | Multiple Myeloma | View Spotlight | |||
OPM-2 | Multiple Myeloma | ||||
Reh | B-cell Acute Lymphoblastic Leukemia | ||||
Reh-Luc-Neo | B-cell Acute Lymphoblastic Leukemia |
| |||
RPMI 8226 | Plasmocytoma | ||||
RS4;11 | B-cell Acute Lymphoblastic Leukemia | ||||
THP-1 | Acute Myeloid Leukemia (monocytic) | ||||
THP-1-Luc-mCh-Puro | Acute Myeloid Leukemia (monocytic) | View Growth Curve | |||
U266B1 | Multiple Myeloma | ||||
Mouse | 5TGM1-Luc | Multiple Myeloma | |||
C1498 | Acute Myeloid Leukemia | ||||
C1498-Luc-mCh-Puro | Acute Myeloid Leukemia | ||||
J558 | Plasmacytoma | ||||
J558-Luc-mCh-Puro | Plasmacytoma |
| |||
L1210 | Leukemia (lymphocytic) | ||||
M-NFS-60 | Leukemia (myeloblastic) | ||||
RAW 264.7 | Leukemia (macrophages) | ||||
Brain | Human | BT142 | Oligoastrocytoma | ||
D54-Luc | Glioblastoma |
|
| ||
DBM2 | Glioblastoma | ||||
DBTRG-05MG | Glioblastoma | ||||
DBTRG-05MG-Luc-mCh-Puro | Glioblastoma | ||||
IMR-32 | Neuroblastoma | View Growth Curve | |||
LN-18 | Glioblastoma | ||||
LN-229 | Glioblastoma | ||||
M059K | Glioblastoma | ||||
SF-295 | Glioblastoma | ||||
SF-539 | Glioblastoma | ||||
SF-767 | Glioblastoma | ||||
SK-N-AS | Neuroblastoma | ||||
SK-N-FI | Neuroblastoma | ||||
SK-N-MC | Neuroepithelioma | ||||
SK-N-SH | Neuroblastoma |
| |||
SNB-19 | Astrocytoma | ||||
T98G | Glioblastoma Multiforme | ||||
U-251 | Astrocytoma | ||||
U-251-Luc-mCh-Puro | Astrocytoma | ||||
U-87 MG | Glioblastoma | ||||
U-87 MG-Luc | Glioblastoma | ||||
Mouse | GL261 | Glioblastoma |
| ||
GL261-Luc2 | Glioblastoma | ||||
Neuro-2a | Neuroblastoma | ||||
Rat | 9L | Gliosarcoma | |||
9L-Luc | Gliosarcoma | ||||
C6 | Glioma | ||||
C6/A | Glioma | ||||
F98 | Glioma (malignant undifferentiated) | ||||
Cervical | Human | HeLa | Cervical Adenocarcinoma | ||
KB | Cervical Adenocarcinoma | ||||
Colon | Human | C2BBe1 | Colorectal Adenocarcinoma | ||
Caco-2 | Colorectal Adenocarcinoma | ||||
COLO 205 | Colorectal Adenocarcinoma (Dukes' type D) | ||||
COLO 205-Luc #2 | Colorectal Adenocarcinoma (Dukes' type D) | ||||
COLO 320 DM | Colorectal Adenocarcinoma (Dukes' type C) | ||||
DLD-1 | Colorectal Adenocarcinoma (Dukes' type C) |
| |||
HCC2998 | Colorectal Adenocarcinoma | ||||
HCT 116 | Colorectal Carcinoma | ||||
HCT 116-Luc | Colorectal Carcinoma |
| |||
HCT-15 | Colorectal Adenocarcinoma (Dukes' type C) | ||||
HCT-8 | Colorectal Adenocarcinoma (ileocecal) |
| |||
HT-29 | Colorectal Adenocarcinoma | ||||
HT-29-Luc | Colorectal Adenocarcinoma | ||||
LoVo | Colorectal Adenocarcinoma (Dukes' type C; grade IV) | View Growth Curve | |||
LS 174T | Colorectal Adenocarcinoma (Dukes' type B) | ||||
LS411N | Colorectal Adenocarcinoma (cecum; Dukes' type B) | ||||
NCI-H508 | Colorectal Adenocarcinoma (cecum) | ||||
SW 1463 | Colorectal Adenocarcinoma (rectum; Dukes' type C) | ||||
SW 48 | Colorectal Adenocarcinoma (Dukes' type C; grade IV) | ||||
SW480 | Colorectal Adenocarcinoma | ||||
SW620 | Colorectal Adenocarcinoma (Dukes' type C) | ||||
SW837 | Colorectal Adenocarcinoma (stage 4) | ||||
Mouse | C26 | Colorectal Carcinoma | |||
C38 | Colorectal Carcinoma | ||||
Colorectal Carcinoma | View Growth Curve | ||||
Colon26-Luc | Colorectal Carcinoma | ||||
Colon 38 | Colorectal Carcinoma | ||||
CT26.WT | Colorectal Adenocarcinoma | ||||
CT26.WT-Luc-mCh-Puro | Colorectal Adenocarcinoma | ||||
MC38-NCI.TD1 | Colorectal Adenocarcinoma | ||||
MC38-NCI.TD1-Luc-mCh-Puro | Colorectal Adenocarcinoma | ||||
Connective | Human | HT-1080 | Fibrosarcoma | ||
SW 872 | Liposarcoma | ||||
Mouse | P815 | Mastocytoma | |||
RIF-1 | Fibrosarcoma | ||||
Embryo | Human | NCCIT | Pluripotent Embryonal Carcinoma (mediastinal mixed germ cell) | ||
Chicken | UMNSAH/DF-1 | Embryonic Fibroblasts | |||
Endometrium | Human | KLE | Endometrial Adenocarcinoma | ||
KLE-Luc-mCh-Puro | Endometrial Adenocarcinoma | ||||
Esophageal | Human | KYSE 30 | Esophageal Squamous Cell Carcinoma (well differentiated; invasive) | ||
KYSE 150 | Esophageal Squamous Cell Carcinoma (poorly differentiated) | ||||
KYSE 410 | Esophageal Squamous Cell Carcinoma (poorly differentiated; invasive) | ||||
KYSE 510 | Esophageal Squamous Cell Carcinoma (well differentiated) | ||||
OE19 | Esophageal Adenocarcinoma | ||||
OE33 | Esophageal Adenocarcinoma | ||||
Gastric | Human | GIST-T1 | Gastrointestinal Stromal Sarcoma | ||
MKN-45 | Gastric Adenocarcinoma | ||||
NCI-N87 | Gastric Adenocarcinoma | ||||
NUGC-4 | Gastric Adenocarcinoma | ||||
SNU-1 | Gastric Adenocarcinoma | ||||
SNU-16 | Gastric Carcinoma | ||||
SNU-5 | Gastric Adenocarcinoma | ||||
OVCAR-5 | Metastatic Gastrointestinal Carcinoma | ||||
OVCAR-5-Luc-mCh-Puro | Metastatic Gastrointestinal Carcinoma | View Growth Curve | |||
Head and Neck | Human | CAL 27 | Tongue Squamous Cell Carcinoma | ||
FaDu | Hypopharyngeal Squamous Cell Carcinoma | ||||
SCC-4 | Tongue Squamous Cell Carcinoma | ||||
Liver | Human | Hep 3B2.1-7 | Hepatocellular Carcinoma | ||
Hep G2 | Hepatoblastoma | ||||
SK-HEP-1 | Hepatocellular Carcinoma | ||||
Mouse | BNL 1ME A.7R.1 | Normal Hepatocytes | |||
BNL 1ME A.7R.1-Luc-mCh-Puro | Normal Hepatocytes | ||||
Hep-55.1C | Hepatocellular Carcinoma | ||||
Hep-55.1C-Luc-mCh-Puro | Hepatocellular Carcinoma | ||||
Hepa 1-6 | Hepatocellular Carcinoma |
| |||
| Hepa 1-6-Luc-mCh-Puro | Hepatocellular Carcinoma | ||||
Lung | Human | A549 | Non-Small Cell Lung Carcinoma (NSCLC) Adenocarcinoma | ||
A549-Luc-C8 | NSCLC Adenocarcinoma |
| |||
Calu-1 | NSCLC (epidermoid) | ||||
Calu-3 | NSCLC Adenocarcinoma | ||||
Calu-6 | Lung Adenocarcinoma (analplastic; metastasis) | View Spotlight | |||
DMS 114 | Small Cell Lung Cancer | ||||
DMS-273 | Small Cell Lung Cancer | ||||
EBC-1 | NSCLC Squamous Cell Carcinoma | ||||
HCC2935 | NSCLC Adenocarcinoma | ||||
HCC44 | NSCLC Adenocarcinoma | ||||
HCC827 | NSCLC Adenocarcinoma | ||||
HCC827-Luc-mCh-Puro | NSCLC Adenocarcinoma |
| |||
LU99 | NSCLC (giant cell) | ||||
MRC-5 | Normal Fibroblasts | ||||
NCI-H1155 | NSCLC (large cell) | ||||
NCI-H125 | NSCLC (adenosquamous) | ||||
NCI-H125-Luc | NSCLC (adenosquamous) | ||||
NCI-H1299 | NSCLC (large cell) | ||||
NCI-H1373 | Lung Adenocarcinoma (stage 3A) | ||||
NCI-H1650 | NSCLC Adenocarcinoma | View Growth Curve | |||
NCI-H1703 | NSCLC Squamous Cell Carcinoma | ||||
NCI-H1703-Luc-mCh-Puro | NSCLC Squamous Cell Carcinoma | ||||
NCI-H1792 | NSCLC Adenocarcinoma (stage 4) | ||||
NCI-H1975 | NSCLC Adenocarcinoma | ||||
NCI-H1975-Luc | NSCLC Adenocarcinoma | View Spotlight | |||
NCI-H2030 | NSCLC Adenocarcinoma | ||||
NCI-H2110 | NSCLC | ||||
NCI-H2122 | NSCLC Adenocarcinoma | ||||
NCI-H23 | NSCLC Adenocarcinoma |
| |||
NCI-H292 | NSCLC Adenocarcinoma |
| |||
NCI-H322M | Bronchioalveolar Adenocarcinoma (minimally invasive) | ||||
NCI-H358 | Bronchioalvelolar Carcinoma (NSCLC) | ||||
NCI-H441 | NSCLC Adenocarcinoma | ||||
NCI-H446 | Small Cell Lung Cancer | ||||
NCI-H460 | NSCLC (large cell) | ||||
NCI-H460-Luc2 | NSCLC (large cell) | ||||
NCI-H520 | NSCLC Squamous Cell Carinoma | ||||
NCI-H522 | NSCLC Adenocarcinoma | ||||
NCI-H596 | Lung Adenosquamous Carcinoma | ||||
NCI-H69 | Small Cell Lung Cancer | ||||
NCI-H727 | Lung Carcinoid (bronchus) | ||||
NCI-H82 | Small Cell Lung Cancer |
| |||
PC-9 | NSCLC Adenocarcinoma | ||||
PC-9-Luc-mCh-Puro | NSCLC Adenocarcinoma | ||||
SHP-77 | Small Cell Lung Cancer | View Growth Curve | |||
SK-MES-1 | NSCLC Squamous Cell Carcinoma | ||||
SW 1573 | Alveolar Cell Carcinoma (minimally invasive) | ||||
Mouse | AB1 | Mesothelioma | |||
AB12 | Mesothelioma | ||||
AB1-Luc-mCh-Puro | Mesothelioma | ||||
ASB | Primary Squamous Cell Carcinoma | ||||
KLN 205 | Squamous Cell Lung Carcinoma | ||||
KLN 205-Luc-mCh-Puro | Squamous Cell Lung Carcinoma | ||||
LC12 | Squamous Cell Lung Carcinoma (advanced stage) | ||||
LL/2 | Lewis Lung Carcinoma | ||||
LL/2-Luc-M38 | Lewis Lung Carcinoma | ||||
Lymph [B-cell] | Human | BJAB | Burkitt’s Lymphoma | ||
Daudi | Burkitt’s Lymphoma | ||||
Daudi-Luc-mCh-Puro | Burkitt’s Lymphoma | ||||
DB | Diffuse Large B-Cell Lymphoma(germinal center B-cell type [GCB]) | ||||
DOHH-2 | Refractory Immunoblastic B-Cell Lymphoma | ||||
Farage | Diffuse Large B-Cell Lymphoma | ||||
Farage-Luc-mCh-Puro | Diffuse Large B-Cell Lymphoma | ||||
GRANTA-519 | Mantle Cell Lymphoma | ||||
HT | Diffuse Large B-Cell Lymphoma(GCB) | ||||
Jeko-1 | Mantle Cell Lymphoma | ||||
NAMALWA | Burkitt’s Lymphoma | ||||
OCI-Ly1 LN | Diffuse Large B-Cell Lymphoma(GCB) | ||||
OCI-Ly1 R7-Luc-mCh-Puro | Diffuse Large B-Cell Lymphoma(GCB) | ||||
OCI-Ly19-Luc-Neo | Diffuse Large B-Cell Lymphoma(GCB) | ||||
OCI-Ly3-Luc-mCh-Puro | Diffuse Large B-Cell Lymphoma(activated B-cell type) | ||||
OCI-Ly7-Luc-Neo | Diffuse Large B-Cell Lymphoma(GCB) | ||||
Pfeiffer | Diffuse Large B-Cell Lymphoma(GCB) | ||||
Raji | Burkitt’s Lymphoma | ||||
Raji-Luc | Burkitt’s Lymphoma | View Growth Curve | |||
Ramos | Burkitt’s Lymphoma |
| |||
Ramos-Luc | Burkitt’s Lymphoma | ||||
RL | Diffuse Large B-Cell Lymphoma | ||||
SU-DHL-10 | Diffuse Large B-Cell Lymphoma(GCB) | ||||
SU-DHL-16 | Diffuse Large B-Cell Lymphoma | ||||
SU-DHL-4-Luc-mCh-Puro | Diffuse Large B-Cell Lymphoma(GCB) | ||||
SU-DHL-6 | Diffuse Large B-Cell Lymphoma(GCB) | ||||
SU-DHL-6-Luc-mCh-Puro | Diffuse Large B-Cell Lymphoma(GCB) | ||||
SU-DHL-8 | Diffuse Large B-Cell Lymphoma(GCB) | ||||
TMD8 | Diffuse Large B-Cell Lymphoma(activated B-cell type) | ||||
Toledo-Luc-Neo | Diffuse Large B-Cell Lymphoma(GCB) | ||||
WSU-DLCL2 | Diffuse Large B-Cell Lymphoma(GCB) | View Growth Curve | |||
WSU-FSCCL | Grade I Follicular Lymphoma | ||||
Mouse | A20 | Reticulum Cell Sarcoma | |||
A20-Luc2-Puro | Reticulum Cell Sarcoma | ||||
J774A.1 | Reticulum Cell Sarcoma (macrophages) | ||||
Lymph [T-cell] | Human | HuT 78 | Cutaneous T Cell Lymphoma (Sezary syndrome) | ||
KARPAS 299 | Anaplastic Large Cell Lymphoma (T-NHL) |
| |||
NK-92MI | Lymphoblastic Lymphoma (natural killer–NHL) | ||||
Mouse | E.G7-OVA | T Lymphoblastic Lymphoma | |||
EL4 | T Lymphoblastic Lymphoma | View Growth Curve | |||
EL4-Luc-mCh-Puro | T Lymphoblastic Lymphoma | ||||
P388D1 | Lymphoblastic Lymphoma (macrophage) |
| |||
YAC-1 | T Lymphoblastic Lymphoma | ||||
Lymph [Histiocytes] | Human | DEL | Malignant Histiocytosis | ||
U-937 | Histiocytic Lymphoma | ||||
Mammary/Breast | Human | AU-565 | Mammary Adenocarcinoma | ||
BT-20 | Breast Ductal Carcinoma (invasive; TNBC) | ||||
BT-474 | Breast Ductal Carcinoma (invasive) | ||||
BT-474-Luc-mCh-Puro | Breast Ductal Carcinoma (invasive) | ||||
HCC1395 | Breast Ductal Carcinoma(TNBC) | ||||
HCC1428 | Mammary Adenocarcinoma (TNM stage IV, grade 4) | ||||
HCC1806 | Breast Squamous Cell Carcinoma | ||||
HCC-38 | Breast Ductal Carcinoma (grade 3) | ||||
HCC70 | Breast Ductal Carcinoma (primary; TNBC) | ||||
Hs 578Bst | Normal Mammary Cells (fibroblastic; myoepithelial) | ||||
Hs 578T | Breast Ductal Carcinoma (invasive; TNBC) | ||||
MCF 10A | Normal Mammary Cells (non-tumorigenic; epit helial) | ||||
MCF7 | Breast Ductal Carcinoma (invasive) | ||||
MCF7-Luc-mCh-Puro | Breast Ductal Carcinoma |
| |||
MDA-MB-231 | Mammary Adenocarcinoma (TNBC) | ||||
MDA-MB-231-2LMP | Mammary Adenocarcinoma | ||||
MDA-MB-231-Luc-D3H1 | Mammary Adenocarcinoma | ||||
MDA-MB-231-Luc-D3H2LN | Mammary Adenocarcinoma | ||||
MDA-MB-361 | Mammary Adenocarcinoma | ||||
MDA-MB-453 | Breast Metastatic Carcinoma | ||||
MDA-MB-453-Luc-mCh-Puro | Breast Metastatic Carcinoma | ||||
SK-BR-3 | Mammary Adenocarcinoma | ||||
T47D | Breast Ductal Carcinoma (invasive) |
| |||
UISO-BCA-1 | Breast Carcinoma (invasive) |
| |||
ZR-75-1 | Breast Ductal Carcinoma (invasive) |
| |||
Mouse | 4T1-Luc2-1A4 | Mammary Carcinoma | |||
E0771 | Mammary Carcinoma | ||||
E0771-Luc-mCh-Puro | Mammary Carcinoma | View Growth Curve | |||
EMT-6 | Mammary Carcinoma | ||||
EMT6-Luc-mCh-Puro | Mammary Carcinoma | View Growth Curve | |||
MMTV-PyMT | Mammary Carcinoma | ||||
Rat | 13762MAT B III | Mammary Adenocarcinoma | |||
Walker256 | Mammary Carcinoma | ||||
Ovarian | Human | A2780 | Ovarian Endometrioid Adenocarcinoma | ||
A2780-Luc | Ovarian Endometrioid Adenocarcinoma | ||||
Caov-3 | Ovarian Adenocarcinoma | ||||
Cov-318 | Ovarian Epithelial-Serous Carcinoma | ||||
EFO-21 | Ovarian Serous Cystadenocarcinoma (dedifferentiated) | ||||
IGROV1 | Ovarian Endometrioid Adenocarcinoma | ||||
IGROV1-Luc-mCh-Puro | Ovarian Endometrioid Adenocarcinoma | ||||
NIH:OVCAR-3 | High-Grade Serous Ovarian Adenocarcinoma | View Spotlight | |||
NIH:OVCAR-3-Luc-mCh-Puro | High-Grade Serous Ovarian Adenocarcinoma | ||||
OV-90 | High-Grade Serous Ovarian Adenocarcinoma | View Growth Curve | |||
OVCAR-4 | High-Grade Serous Ovarian Adenocarcinoma | ||||
OVCAR-8 | Ovarian Adenocarcinoma | ||||
OVCAR-8-Luc-mCh-Puro | Ovarian Adenocarcinoma | ||||
PA-1 | Ovarian Teratocarcinoma | View Growth Curve | |||
SK-OV-3 | Ovarian Serous Cystadenocarcinoma | ||||
SK-OV-3-Luc-D3 | Ovarian Serous Cystadenocarcinoma | ||||
Mouse | ID8 | Epithelial Ovarian Carcinoma | |||
ID8-Luc-mCh-Puro | Epithelial Ovarian Carcinoma | ||||
Pancreas | Human | AsPC-1 | Pancreatic Ductal Adenocarcinoma | ||
BxPC-3 | Pancreatic Ductal Adenocarcinoma | ||||
BxPC-3-Luc2 | Pancreatic Ductal Adenocarcinoma | ||||
Capan-1 | Pancreatic Ductal Adenocarcinoma | ||||
Capan-2 | Pancreatic Ductal Adenocarcinoma |
| |||
| CFPAC-1 | Pancreatic Ductal Adenocarcinoma | ||||
HPAF-II | Pancreatic Adenocarcinoma | ||||
KP4 | Pancreatic Ductal Adenocarcinoma |
| |||
MIA PaCa-2 | Pancreatic Ductal Adenocarcinoma | View Spotlight | |||
MIA PaCa-2-Luc | Pancreatic Ductal Adenocarcinoma | ||||
PA-TU-8988T | Pancreatic Adenocarcinoma | ||||
PANC-1 | Pancreatic Ductal Adenocarcinoma (epthelioid) | ||||
PANC-1-Luc | Pancreatic Ductal Adenocarcinoma |
| |||
SU.86.86 | Pancreatic Ductal Adenocarcinoma | ||||
SW 1990 | Pancreatic Ductal Adenocarcinoma | View Growth Curve | |||
Mouse | Pan02.TD1 | Pancreatic Adenocarcinoma |
| ||
| Pan02.TD1-Luc-mCh-Puro | Pancreatic Adenocarcinoma | ||||
Pan 03 | Pancreatic Carcinoma | ||||
Pan 03/NIH | Pancreatic Carcinoma | ||||
Rat | AR42J | Pancreatic Carcinoma | |||
Pharynx | Human | Detroit 562 | Pharyngeal Squamous Cell Carcinoma | ||
Placenta | Human | BeWo | Gestational Choriocarcinoma | ||
Prostate | Human | 22Rv1 | Prostate Carcinoma | ||
CWR-22-R | Prostate Carcinoma | ||||
DU 145 | Prostate Carcinoma | ||||
DU 145-Luc | Prostate Carcinoma | ||||
LNCaP clone FGC | Prostate Carcinoma | ||||
PC-3 | Prostate Adenocarcinoma | ||||
PC-3M-Luc-C6 | Prostate Carcinoma | ||||
VCaP | Prostate Carcinoma | ||||
Mouse | RM-1 | Prostate Carcinoma | |||
RM-1-Luc-mCh-Puro | Prostate Carcinoma | ||||
Renal | Human | 293 | Normal Renal Cells (embryonic) | ||
293-Luc-mCh-Puro | Normal Renal Cells | ||||
769-P | Clear Cell Renal Cell Carcinoma | ||||
786-O | Clear Cell Renal Cell Carcinoma | View Growth Curve | |||
786-O-Luc-Neo (rescued) | Clear Cell Renal Cell Carcinoma | ||||
A-498 | Renal Cell Adenocarcinoma | ||||
ACHN | Renal Cell Adenocarcinoma | ||||
Caki-1 | Clear Cell Renal Cell Carcinoma | View Growth Curve | |||
RPTEC | Normal Renal Cells (proximal tubule epithelial cells) | ||||
TK-10 | Renal Cell Adenocarcinoma | ||||
African Green Monkey | COS-7 | Normal Renal Cells (non-human, primate) | |||
Mouse | Renca | Renal Cell Carcinoma | |||
Skin | Human | A2058 | Malignant Melanoma (amelanotic) | ||
A-253 | Epidermoid Carcinoma (submaxillary salivary gland) | ||||
A-375 | Malignant Melanoma (amelanotic) | ||||
A-375-Luc-mCh-Puro | Malignant Melanoma (amelanotic) | ||||
A-431 | Epidermoid Carcinoma (squamous cell) | ||||
COLO 829 | Dermal Fibroblasts(cutaneous malignant melanoma) | ||||
G-361 | Amelanotic Melanoma | ||||
HEKn | Primary Epidermal Keratinocytes (neonatal foreskin) | ||||
HEKn-2 | Primary Epidermal Keratinocytes (neonatal foreskin) | ||||
HMCB | Melanoma | ||||
Hs 895.Sk | Dermal Fibroblasts (normal) | ||||
LOX-IMVI | Amelanotic Melanoma |
| |||
M14 | Amelanotic Melanoma | ||||
MKL-1 | Neuroendocrine Skin (Merkel Cell) Carcinoma | ||||
NHDF | Dermal Fibroblasts (primary; normal) | ||||
OCM-1 | Melanoma | ||||
OCM-1-Luc-mCh-Puro | Melanoma | ||||
PA-NUT | Melanoma | ||||
SK-MEL-28 | Amelanotic Melanoma | ||||
SK-MEL-28-Luc-mCh-Puro | Amelanotic Melanoma | ||||
SK-MEL-3 | Malignant Melanoma | ||||
SK-MEL-5 | Malignant Melanoma (cutaneous) | ||||
UACC-62 | Malignant Melanoma (melanotic) | ||||
WM-115 | Malignant Melanoma (superficial spreading) | ||||
WM-266-4 | Amelanotic Melanoma | ||||
Mouse | B16 | Melanoma | |||
B16-F10 | Melanoma | ||||
B16-F10-Luc-G5 | Melanoma | ||||
B16-F10-Luc2 | Melanoma | ||||
Cloudman S91 | Melanoma | ||||
Cloudman S91-Luc-mCh-Puro | Melanoma | ||||
YUMM1.7 | Melanoma | ||||
YUMM1.7-Luc-mCh-Puro | Melanoma | ||||
Thyroid | Human | MB-1 | Thyroid Carcinoma (anaplastic) | ||
TT | Thyroid Carcinoma (medullary) | ||||
Vulva | Human | SK-LMS-1 | Vulva Leiomyosarcoma |